BIOTIN

The aim is to train enterprising and adaptable generalist engineers in the biotechnology-health sector by ensuring that students are fully equipped to pursue a career in either the health, industrial, or academic sectors. The multidisciplinary nature of the master's program allows students to focus on therapeutic, diagnostic, medical device, or bioproduction fields. All related activities are accessible: research, development, regulatory affairs, and clinical trials.

• Good knowledge in all areas of modern biology and biotechnology (omics, genomics, immunology and immunotherapies, bioinformatics, AI, biomarkers, gene and cell therapy, personalized medicine, diagnostic innovations, clinical biology, clinical trials, bioproduction).
• English with TOEIC
• 11 months of internships (5 months in M1 and 6 months in M2)
• Knowledge of the field: innovation, patents, project management, business creation (including innovation camps, creative retreats, and participation in conferences).

The class of 2020-21 is diverse, comprising seven nationalities; outside of the pandemic period, approximately one-third of internships are completed abroad.